CD4 and esophageal squamous cell carcinoma: The results likewise showed that the m6A epigenetic-based riskscore was significantly correlated with multiple immune cell types, with ESCC patients with higher riskscore having lower expression levels of their major immune cells, with this difference being reflected mainly in NKT, CD4+ naive T cells, M1 macrophages, aDC, and macrophages.